Such impacts occur where other neglected diseases
break out but do not get reported.
The trend in approvals is clearly going in the right direction, but annual R&D spending to treat neglected diseases
has leveled off at $3 billion in total, after rising rapidly from 2000 to 2007, which is a cause of concern," points out Joshua Cohen, assistant professor at Tufts CSDD who served as principal investigator on the study.
Developing new health technologies for neglected diseases
is a difficult business strategy to pursue.
Don remains upbeat about the current challenges regarding neglected disease
They employ empirical data about neglected diseases
and the current pharmaceutical market to draw support for a scheme encouraging vaccine development for such diseases.
Those stricken with neglected diseases
do not constitute a valuable enough market to stimulate adequate R&D for new medicines by the multinational pharmaceutical industry.
According to the report, product development partnerships (PDPs) -- a unique public-private partnering mechanism created to increase biopharmaceutical participation in neglected disease
R&D, government agencies, and academic institutions -- are driving this biotechnology company partnering for neglected diseases
Partnering is an important driver for today's biotechnology companies, according to the report, "Biotechnology: Bringing Innovation to Neglected Disease
Research and Development" The research finds 64% of all products in development by biotechnology companies across the pipeline of drugs, vaccines and diagnostics for neglected diseases
The new designation follows the release of a recent report concluding that high blood pressure is a neglected disease
in the U.
The TRND program provides an opportunity to partner with and gain access to rare and neglected disease
drug development capabilities, expertise, and clinical/regulatory resources in a collaborative environment with the goal of moving promising therapeutics into human clinical trials.
Global health experts, healthcare providers, people living with RHD and others called for new action against this easily preventable but neglected disease
, which is a major cause of serious illness and death among women, children and adolescents in developing countries.
The articles published over these two special issues will provide valuable insights into the current contributions of medicinal chemistry efforts to neglected disease
research, said Dr Kaneko.